Genetics Squared's technology and methods offer flexible and powerful analysis to identify and combine drug-related biomarkers using the data you already have. The company seeks relationships with biopharmaceutical companies that will allow us to provide a high-value patient stratification service in return for fees, milestone payments and/or long-term royalty interest.

This service may best be applied to compounds that have shown promise early in development, but are either lacking broad efficacy within the population or experiencing adverse events that have been difficult to isolate.

Post Market Applications

We are also in discussion with pharmaceutical companies to conduct projects with products already approved for market in order to identify specific patient populations with extra therapeutic benefit in order to expand patent position and improve reimbursement scenario

Uniqueness

Our approach is unique is its capability to:

• analyze data from any combination of data types (i.e. genomic, protein chemistry, clinical, etc)
  
  
• provide results in the form of human comprehensible rules
  
  
• select from thousands of variables without bias
  
  
• optimize rules based on ease of collecting specific data types in a clinical setting
  
  
• provide results utilizing very few variables (usually less than ten - often just a few)

Contact Genetics Squared today to learn more and keep your drug headed for approval and post-market success.